Research Article

Clinical Arterial Peripheral Vascular Pathology Does Not Impact Short- or Long-Term Survival after Transcatheter Aortic Valve Replacement

Table 1


Vascular Pathology (n=147)Control (n=195)P-value

Age80.6 (7.55)78.1 (9.76).011

Male sex67 (99)47 (92)<.001

BMI29.7 (6.04)31.0 (6.34).344

Caucasian race 99 (145)99 (194)1.000

EuroSCORE ()10.91 (6.90)6.84 (5.29)<.001

STS Risk Score ()8.35 (4.67)5.48 (3.03)<.001

Preprocedural HTN88 (129)88 (172)1.000

Preprocedural CAD87 (128)63 (123)<.001

Baseline Ejection Fraction <4017 (25)12 (24).275

Preprocedural NYHA45 (66)44 (85).827
Class III OR IV Symptoms

Preprocedural DM36 (53)35 (68).820

Prior Stroke/TIA16 (24)8 (15).016

Preprocedural Atrial Fibrillation 35 (52)27 (52).097

Preprocedural Serum Creatinine (mg/dL)1.46 (1.14)1.11 (0.46)<.001

Preprocedural eGFR < 60 mL/min55 (81)43 (83).022

Preprocedural Dyslipidemia100 (147)83 (162)<.001

Preprocedural AAA26 (38)--

Preprocedural Carotid Artery 63 (93)--
Stenosis >50 or Prior CEA

Preprocedural Symptomatic PAD64 (94)--

Prior CABG35 (52)23 (44).011

Prior PCI44 (65)31 (60).013

Prior Permanent Pacemaker13 (19)11 (22).737

Prior Aortic Valvuloplasty19 (28)16 (31).472

Cardiovascular Pharmacology

 ACE inhibitor 34 (50)31 (61).641

 Angiotensin II receptor blocker 14 (20)21 (40).114

 Beta blocker ()78 (114)71 (138).174

 Calcium channel blocker 26 (38)30 (59).398

 Thiazide diuretic 19 (28)22 (43).590

 Loop diuretic 52 (77)47 (92).382

 Spironolactone 3 (4)4 (8).565

 Statin 77 (113)66 (128).031

 Aspirin84 (123)70 (136).003

 Dual Antiplatelet Therapy36 (53)22 (42).003

 Any anticoagulant 28 (41)23 (45).317

Values are mean (standard deviation) or % (n).